The medical coordinator of the Multidisciplinary Sleep-Wake Disorders Center at Antwerp University Hospital spoke about how to address some of the issues faced in OSA treatment development.
Johan Verbraecken, MD, PhD
Advertisement
Articles by Johan Verbraecken, MD, PhD
Advertisement
Latest Updated Articles
Johan Verbraecken, MD, PhD: Challenges in Conducting Clinical Trials in OSAPublished: October 8th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
2
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
3
Analyzing Subgroup Data From the TRAILBLAZER-ALZ 2 Study of Donanemab: Brandy Matthews, MD
4
Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease
5
